Lung Cancer Canada Podcasts

On this episode, PrecisCa speaks with Dr. Michael Lanuti, an Associate Professor of Surgery at Harvard Medical School & the Director of Thoracic Oncology, Division of Thoracic Surgery at Massachusetts General Hospital. Dr. Lanuti sits down with PrecisCa to discuss the following: What tests need to be ordered before surgery for lung cancer? Which pa…

Part 4 of the series, Dr. Paul Wheatley-Price speaks with Dr. Garth Nicholas, of The Ottawa Hospital about clinical trials that changed how lung cancer is treated. Based on Dr. Nicholas' fascinating and informative tweets for Lung Cancer Awareness Month in November 2021. You can find Dr. Nicholas on twitter @GarthNicholas1.…

On this episode, PrecisCa speaks with Dr. Joyce O'Shaughnessy, a medical oncologist and the Director of Breast Cancer Research Program at Baylor University Medical Center in Dallas, Texas. Dr. O'Shaughnessy sits down with us to answer the following questions: Which breast cancer patients are eligible for preoperative pembrolizumab in the curative s…

On this episode, PrecisCa speaks with Dr. Suresh Ramalingam, medical oncologist and Executive Director at the Winship Cancer Institute of Emory University in Atlanta, Georgia. Dr. Ramalingam sits down with us to answer the following questions: What is the prognosis of lung cancer by stage? What are the side effects of targeted therapy for lung canc…

Part 3 of the series, Dr. Paul Wheatley-Price speaks with Dr. Garth Nicholas, of The Ottawa Hospital about clinical trials that changed how lung cancer is treated. Based on Dr. Nicholas' fascinating and informative tweets for Lung Cancer Awareness Month in November 2021. You can find Dr. Nicholas on twitter @GarthNicholas1.…

On this episode, PrecisCa speaks with Yi-Bin Chen MD, MS. Dr. Chen is the Director of the Transplant and Cell Therapy program at Massachusetts General Hospital/Harvard Medical School -- uniting the programs of conventional transplant and emerging cellular therapies. His clinical interests mainly revolve around improving the outcomes of patients und…

On this episode, PrecisCa speaks with David M. Schuster MD, FACR. Dr. Schuster is a Professor in the Department of Radiology and Imaging Sciences at Emory University School of Medicine. Dr. Schuster also serves as Director of the Division of Nuclear Medicine and Molecular Imaging, and is a Georgia Research Alliance Distinguished Scientist. Board ce…

Dr. Collins graduated from the University of Florida with a Bachelor of Science in Biology and again with her Master of Science in Human Nutrition. She started her career with the National Institute of Health Clinical Research Center in Charlottesville, VA. In 2007 she graduated from the University of Tennessee, Knoxville with her Ph.D. in Experime…

Part 2 in this series, Dr. Paul Wheatley-Price speaks with Dr. Garth Nicholas, of The Ottawa Hospital about clinical trials that changed how lung cancer is treated. Based on Dr. Nicholas' fascinating and informative tweets for Lung Cancer Awareness Month in November 2021. You can find Dr. Nicholas on twitter @GarthNicholas1.…

On this episode we hear from Thoracic Medical oncologist Dr. Thomas Stinchcombe. Dr. Stinchcombe is a member of Duke Cancer Institute, and Thoracic Oncology Program at Duke University in Durham, North Carolina. Dr. Stinchcombe explains whether or not they would recommend RET inhibitors as first line therapy for a RET-fusion positive metastatic Non-…

On this episode we hear from Dr. Monica Morrow. Dr. Morrow is Anne Burnett Windfohr Chair of Clinical Oncology, Professor of Surgery at Memorial Sloan Kettering Cancer Center in New York City. She is a surgical oncologist with a practice dedicated to the treatment of breast cancer. Her research has focused on how to apply the advances from clinical…

In the first of a series, Dr. Paul Wheatley-Price speaks with Dr. Garth Nicholas, of The Ottawa Hospital about clinical trials that changed how lung cancer is treated. Based on Dr. Nicholas' fascinating and informative tweets for Lung Cancer Awareness Month in November 2021. You can find Dr. Nicholas on twitter @GarthNicholas1.…

On this episode we hear from Dr. Steven Poplack from Stanford University. Dr. Poplack explains the various types of breast biopsies, the difference between screening and diagnostic imaging & how often breast cancer survivors should undergo breast cancer screening.By PrecisCa

PrecisCa sits down with Dr. Tari King and Dr. Monica Morrow as they answer select questions about breast surgery.By PrecisCa

Drs. Terry Mamounas & Mark Pegram discuss exciting new developments from the 2021 San Antonio Breast Cancer Symposium. See our Abstract outlining the value of virtual tumor boards presented at SABCS21 HEREBy PrecisCa

Drs. Joyce O'Shaughnessy & Ann O'Dea discuss exciting new developments from the 2021 San Antonio Breast Cancer Symposium. See our Abstract outlining the value of virtual tumor boards presented at SABCS21 HEREBy PrecisCa

Continuing our special series, What's New In: Dr. Wheatley Price discusses new advances in Radiotherapy with Dr. Corinne Faivre-Finn of the NHS Foundation Trust and Dr. David Palma of the London Health Sciences Centre. This webinar aired on December 1, 2021,By Lung Cancer Canada

PrecisCa sits down with Dr. Frank Vicini, a Clinical Professor of Breast Radiation Oncology with Genesis Care, in Farmington Hills, Pontiac, & Troy, MIBy PrecisCa

In this special episode that aired as a webinar in our What's New In: series, Dr. Paul Wheatley-Price discusses the newest and upcoming treatments for rare cancer subtypes like RET, MET, HER2 and more with Dr. Alexander Drilon of the Memorial Sloan Kettering Cancer Center, and Dr. Parneet Cheema of the William Osler Health System…

PrecisCa sits down with Dr. Cliff Robinson to answer patients questions about undergoing radiation therapy, and Dr. Cindy Collins discusses dealing with anxiety and depression during treatment. visit us at www.precisca.com contact: podcast@precisca.comBy PrecisCa

PrecisCa sits down with faculty members Dr. Ross Camidge, Dr. Benjamin Levy, Dr. Cliff Robinson, Dr. Jack West, & Dr. Thomas Stinchcombe as they share stories of exceptional responders with lung cancer. visit us at www.precisca.com contact: podcast@precisca.comBy PrecisCa

On today’s program we hear from 5 gastrointestinal oncologists - Doctors Christopher Lieu, Samuel Klempner, Michael Pishvaian, Daniel Catenacci, & Al Benson. These PrecisCa faculty members share stories of GI cancer patients that responded well to novel treatments, clinical trials, or emerging research. visit us at www.precisca.com contact: podcast…

In this episode, Dr. Wheatley-Price speaks to lung cancer survivor, Terry Morey and his wife, Joyce Morey about Terry's cancer journey and the invaluable role of a caregiver.By Lung Cancer Canada

PrecisCa sits down with faculty members Sara Hurvitz MD , William Gradishar MD, Joyce O’Shaughnessy MD & Mark Pegram MD, to share stories of cancer patients that responded well to novel treatments, clinical trials, or their research. visit us at www.precisca.com contact: podcast@precisca.comBy PrecisCa

In this episode, Dr. Paul Wheatley-Price speaks to Dr. Doreen Ezeife, Tom Baker Cancer Centre, Calgary, and Dr. Rosalyn Juergens, Juravinski Cancer Centre, Hamilton, about the highlights of lung cancer research in 2021.By Lung Cancer Canada

Lung Cancer Voices - Jill Hamer Wilson by Lung Cancer CanadaBy Lung Cancer Canada

In this special edition, we present our previously recorded webinar What's New In: Mesothelioma, a moderated discussion of new treatments, techniques and protocols in mesothelioma. Co-hosted by the Canadian Mesothelioma Foundation. For more information visit: https://cmfonline.orgBy Lung Cancer Canada

Dr. Paul Wheatley-Price sits down with Dr. Gwyn Bebb in this week's episode of Lung Cancer Voices to discuss the importance of lung cancer research.By Lung Cancer Canada

In this throwback episode with the 2021 International Association for the Study of Lung Cancer conference taking place, Dr. Paul Wheatley-Price interviews Kirsten Ito, Associate Director, IASLC Foundation and Patient Advocacy, about the opportunities for patient involvement with the IASLC. Registration to the 2021 virtual conference, taking place n…

In this episode, we present our next edition of What's New In: a moderated discussion of the findings presented at the American Society for Clinical Oncology Conference held Jun 4-8, 2021.By Lung Cancer Canada

In this episode, Dr. Paul Wheatley-Price speaks with Tim Monds, retired Educator, School Superintendent and lung cancer survivorBy Lung Cancer Canada

In this eye-opening episode, Dr. Paul Wheatley-Price speaks to Dr. Hsien Seow, PhD and Dr. Samantha Winemaker, MD. They dispel the myths and promote the benefits of early palliative care for lung cancer patients. They are the creators of the 5 star rated Waiting Room Revolution podcast, which can be found here: https://www.waitingroomrevolution.com…

This episode was originally recorded as a webinar in our What's New In: series held on Mar 26, 2021. Dr. Julie Brahmer, MD, Johns Hopkins Medicine and Dr. Rosalyn Juergens, MD, PhD, Juravinski Cancer Centre, discuss the latest advances in immunotherapy for the treatment of lung cancer. Moderated by Dr. Paul Wheatley-Price.…

In this episode, Dr. Anne Gonzalez, MD, MSc, McGill University Health Centre, winner of the 2020 Lung Cancer Canada Geoffrey Ogram Memorial Research Grant, discussed her research on predicting risk of lung cancer in patients with COPD.By Lung Cancer Canada

In this episode, Paul Wheatley-Price speaks to Elya Martinson, mom of 3, university student, and lung cancer "thriver", who was diagnosed during COVID-19.By Lung Cancer Canada

In this episode, Dr Paul Wheatley-Price interviews Darin Diehl, content marketing thought leader, journalist, and lung cancer patient diagnosed during COVID-19.By Lung Cancer Canada

Join us for another special episode from our What's New In: webinar series. This episode is a discussion of findings presented at the Canadian Lung Cancer Conference held February 9-10, 2021. Moderated by Dr. Paul Wheatley-Price and Featuring Dr. Justin Gainor, MD, Medical Oncologist, Massachusetts General Hospital, Boston and Dr. Cheryl Ho, MD, FR…

The next in our Webinar Series: What's New In, in this episode, Dr. Paul Wheatley-Price discusses upcoming treatments, studies breakthroughs, and the future of lung cancer with Dr. Frances Shepherd, MD, FRCPC, Medical Oncologist at Princess Margaret Hospital in Toronto.By Lung Cancer Canada

In this special episode we continue our webinar series, What's New In: with Dr. Paul Wheatley-Price moderating a discussion of ALK positive lung cancer and treatments. Featuring Dr. Natasha Leighl, BSc, MMSc, MD, Medical Oncologist, Princess Margaret Hospital and Dr. Ross Camidge, MD, PhD, Medical Oncologist, University of Colorado Hospital.…

In this special podcast, we present the premiere episode of our webinar series: What's New In:. This episode is a moderated discussion of EGFR positive lung cancer that includes the beginning and evolution of treatment, current treatments, and what’s next.By Lung Cancer Canada

In this episode, Dr. Paul Wheatley Price speaks to Dr. Matthew Steliga, Thoracic Surgeon, Winthrop P. Rockefeller Cancer Institute, Little Rock, AR about the benefits of quitting smoking and new tools to help patients quit.By Lung Cancer Canada

In this episode, Dr. Paul Wheatley-Price speaks with Natalie Fitzgerald, Director, Performance, and Erika Nicholson, Director, Screening & Atlantic Region Lead of the Canadian Partnership Against Cancer (CPAC) about the CPAC report: "Lung cancer and equity: A focus on income and geography" and the findings that influence treatment and outcomes for …

In this special edition tie-in with The 2020 Faces of Lung Cancer Report, Dr. Paul Wheatley-Price speaks with Natalie Fitzgerald, Director, Performance, and Erika Nicholson, Director, Screening & Atlantic Region Lead of the Canadian Partnership Against Cancer (CPAC) about the impact that screening could have on the incidence of lung cancer and some…

In this episode, Dr Paul Wheatley-Price speaks once again to Dr Kevin Jao, who is a medical oncologist drafted to treat COVID-19 in Montreal. For more information on COVID-19 and lung cancer, read the 2020 Faces of Lung Cancer COVID-19 insert, available here: https://www.lungcancercanada.ca/LungCancerCanada/media/Documents/COVID-19-Report-ENG-(1).p…

In this special edition for Lung Cancer Awareness Month, Dr. Paul Wheatley-Price talks to Dr. Brandon Sheffield, Pathologist, William Osler Health about how biomarker testing is done and how it can change treatment plans. For more information about testing, treatment and screening in Canada, read our 2020 Faces of Lung Cancer Report here: https://b…

In this episode, Dr. Paul Wheatley-Price speaks with Allice Legat, a practicing anthropologist in the Northwest Territories, published author and lung cancer survivor.By Lung Cancer Canada

In this special podcast, we present part 2 of "Highlights from ASCO and World Lung 2020" , which was originally broadcast as a webinar on August 14, 2020, hosted by Dr. Paul Wheatley-Price and featuring:Dr Sanjay Popat, BSc, MBBS, FRCP, MD, Medical Oncologist, Royal Marsden Hospital, LondonDr Jonathan Riess, MD, MS, Medical Oncologist, UC Davis Can…

In this special podcast, we present part 1 of "Highlights from ASCO and World Lung 2020" , which was originally broadcast as a webinar on August 14, 2020, hosted by Dr. Paul Wheatley-Priceand featuring:Dr Sanjay Popat, BSc, MBBS, FRCP, MD, Medical Oncologist, Royal Marsden Hospital, LondonDr Jonathan Riess, MD, MS, Medical Oncologist, UC Davis Canc…

In this special edition for World Lung Cancer Day, Dr. Paul Wheatley-Price moderates a debate between Dr. Parneet Cheema, Medical Oncologist, William Osler Health, and Dr. Randeep Sangha, Medical Oncologist, Cross Cancer Institute, on whether recent advances in detection and treatment have made lung cancer a chronic disease.…

In this “Throwback” episode released 1 year ago, Dr. Paul Wheatley-Price interviews lung cancer survivor Mariel Bouris. A special thank you to the Bouris family for providing the funding for the beginning of our program!By Lung Cancer Canada